336 related articles for article (PubMed ID: 37329384)
21. Osteosarcoma of the extremities with synchronous lung metastases: long-term results in 44 patients treated with neoadjuvant chemotherapy.
Bacci G; Briccoli A; Mercuri M; Ferrari S; Bertoni F; Gasbarrini A; Fabbri N; Cesari M; Forni C; Campanacci M
J Chemother; 1998 Feb; 10(1):69-76. PubMed ID: 9531078
[TBL] [Abstract][Full Text] [Related]
22. Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patients.
Starzer AM; Berghoff AS; Hamacher R; Tomasich E; Feldmann K; Hatziioannou T; Traint S; Lamm W; Noebauer-Huhmann IM; Furtner J; Müllauer L; Amann G; Bauer S; Schildhaus HU; Preusser M; Heller G; Brodowicz T
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33762319
[TBL] [Abstract][Full Text] [Related]
23. Innovative approaches for treatment of osteosarcoma.
Rothzerg E; Pfaff AL; Koks S
Exp Biol Med (Maywood); 2022 Feb; 247(4):310-316. PubMed ID: 35043695
[TBL] [Abstract][Full Text] [Related]
24. Novel therapeutic agents for osteosarcoma.
O'Day K; Gorlick R
Expert Rev Anticancer Ther; 2009 Apr; 9(4):511-23. PubMed ID: 19374604
[TBL] [Abstract][Full Text] [Related]
25. Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes.
Ligon JA; Choi W; Cojocaru G; Fu W; Hsiue EH; Oke TF; Siegel N; Fong MH; Ladle B; Pratilas CA; Morris CD; Levin A; Rhee DS; Meyer CF; Tam AJ; Blosser R; Thompson ED; Suru A; McConkey D; Housseau F; Anders R; Pardoll DM; Llosa N
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34021032
[TBL] [Abstract][Full Text] [Related]
26. The effect of immune checkpoint inhibitors on lung metastases of osteosarcoma.
Shimizu T; Fuchimoto Y; Fukuda K; Okita H; Kitagawa Y; Kuroda T
J Pediatr Surg; 2017 Dec; 52(12):2047-2050. PubMed ID: 28954696
[TBL] [Abstract][Full Text] [Related]
27. Advances in Bone-targeted Drug Delivery Systems for Neoadjuvant Chemotherapy for Osteosarcoma.
Li CJ; Liu XZ; Zhang L; Chen LB; Shi X; Wu SJ; Zhao JN
Orthop Surg; 2016 May; 8(2):105-10. PubMed ID: 27384718
[TBL] [Abstract][Full Text] [Related]
28. A curative treatment strategy using tumor debulking surgery combined with immune checkpoint inhibitors for advanced pediatric solid tumors: An in vivo study using a murine model of osteosarcoma.
Shimizu T; Fuchimoto Y; Okita H; Fukuda K; Kitagawa Y; Ueno S; Kuroda T
J Pediatr Surg; 2018 Dec; 53(12):2460-2464. PubMed ID: 30266483
[TBL] [Abstract][Full Text] [Related]
29. Histone deacetylase inhibition prevents the growth of primary and metastatic osteosarcoma.
McGuire JJ; Nerlakanti N; Lo CH; Tauro M; Utset-Ward TJ; Reed DR; Lynch CC
Int J Cancer; 2020 Nov; 147(10):2811-2823. PubMed ID: 32599665
[TBL] [Abstract][Full Text] [Related]
30. Cracking the code: Deciphering the role of the tumor microenvironment in osteosarcoma metastasis.
Jin J; Cong J; Lei S; Zhang Q; Zhong X; Su Y; Lu M; Ma Y; Li Z; Wang L; Zhu N; Yang J
Int Immunopharmacol; 2023 Aug; 121():110422. PubMed ID: 37302370
[TBL] [Abstract][Full Text] [Related]
31. [Results of treatment in primary disseminated osteosarcoma. Analysis of the follow-up of patients in the cooperative osteosarcoma studies COSS-80 and COSS-82].
Winkler K; Torggler S; Beron G; Bode U; Gerein V; Jürgens H; Kusnierz-Glaz C; Kotz R; Salzer-Kuntschik M; Schmoll HJ
Onkologie; 1989 Apr; 12(2):92-6. PubMed ID: 2660050
[TBL] [Abstract][Full Text] [Related]
32. Immune Checkpoint Inhibitors With or Without Bone-Targeted Therapy in NSCLC Patients With Bone Metastases and Prognostic Significance of Neutrophil-to-Lymphocyte Ratio.
Bongiovanni A; Foca F; Menis J; Stucci SL; Artioli F; Guadalupi V; Forcignanò MR; Fantini M; Recine F; Mercatali L; Spadazzi C; Burgio MA; Fausti V; Miserocchi A; Ibrahim T
Front Immunol; 2021; 12():697298. PubMed ID: 34858389
[TBL] [Abstract][Full Text] [Related]
33. The Osteosarcoma Microenvironment: A Complex But Targetable Ecosystem.
Corre I; Verrecchia F; Crenn V; Redini F; Trichet V
Cells; 2020 Apr; 9(4):. PubMed ID: 32326444
[TBL] [Abstract][Full Text] [Related]
34. Osteosarcoma: review of the past, impact on the future. The American experience.
Jaffe N
Cancer Treat Res; 2009; 152():239-62. PubMed ID: 20213394
[TBL] [Abstract][Full Text] [Related]
35. Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma.
Harting MT; Blakely ML; Jaffe N; Cox CS; Hayes-Jordan A; Benjamin RS; Raymond AK; Andrassy RJ; Lally KP
J Pediatr Surg; 2006 Jan; 41(1):194-9. PubMed ID: 16410132
[TBL] [Abstract][Full Text] [Related]
36. Molecular Signaling Pathways as Potential Therapeutic Targets in Osteosarcoma.
Dana PM; Sadoughi F; Asemi Z; Yousefi B
Curr Med Chem; 2022; 29(25):4436-4444. PubMed ID: 35139778
[TBL] [Abstract][Full Text] [Related]
37. Osteosarcoma of the extremity metastatic at presentation: results achieved in 26 patients treated with combined therapy (primary chemotherapy followed by simultaneous resection of the primary and metastatic lesions).
Bacci G; Picci P; Briccoli A; Avella M; Ferrari S; Femino FP; Monti C; Ruggieri P; Rizzente AG; Casadei R
Tumori; 1992 Jun; 78(3):200-6. PubMed ID: 1440945
[TBL] [Abstract][Full Text] [Related]
38. IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis.
Gross AC; Cam H; Phelps DA; Saraf AJ; Bid HK; Cam M; London CA; Winget SA; Arnold MA; Brandolini L; Mo X; Hinckley JM; Houghton PJ; Roberts RD
JCI Insight; 2018 Aug; 3(16):. PubMed ID: 30135299
[TBL] [Abstract][Full Text] [Related]
39. MAPK pathways regulation by DUSP1 in the development of osteosarcoma: Potential markers and therapeutic targets.
Lopes LJS; Tesser-Gamba F; Petrilli AS; de Seixas Alves MT; Garcia-Filho RJ; Toledo SRC
Mol Carcinog; 2017 Jun; 56(6):1630-1641. PubMed ID: 28112450
[TBL] [Abstract][Full Text] [Related]
40. Recurrent delayed immune-related pneumonitis after immune-checkpoint inhibitor therapy for advanced osteosarcoma.
Küçükarda A; Gökmen İ; Özcan E; Peker P; Akgül F; Çiçin İ
Immunotherapy; 2022 Apr; 14(6):395-399. PubMed ID: 35152716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
